U.S. market Open. Closes in 3 hours 7 minutes

RDY | Dr. Reddy's Laboratories Limited Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-31
Revenue279.16B245.88B214.39B189.72B174.60B153.85B142.03B140.81B154.71B148.19B132.17B116.27B96.74B74.69B70.28B69.44B50.01B65.25B24.33B19.47B20.12B18.02B16.60B10.94B
Cost of Revenue115.56B42.91B100.55B86.64B80.59B70.42B65.72B62.45B62.43B62.79B56.37B55.69B43.43B34.43B33.94B32.94B24.60B34.30B12.45B9.39B9.37B7.82B6.86B5.72B
Gross Profit163.61B202.97B113.84B103.08B94.01B83.43B76.30B78.36B92.28B85.40B75.80B60.58B53.30B40.26B36.34B36.50B25.41B30.95B11.88B10.09B10.76B10.20B9.74B5.22B
Operating Expenses98.30B117.61B76.80B70.12B61.25B62.54B64.33B64.78B62.55B58.97B49.82B38.92B33.99B27.63B25.73B25.31B22.05B19.70B10.43B10.45B8.67B6.86B4.68B3.73B
Selling, General & Admin77.20B105.93B62.08B54.56B50.13B48.89B46.91BN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Research & Development22.87B19.38B17.48B16.54B15.41B15.61B18.27B19.55B17.83B17.45B12.40B7.67B5.91B5.06B3.79B4.04B3.53B2.47B2.16B2.80B2.00B1.37B740.85M506.99M
Other Operating ExpensesN/A-7.70B-2.76B-982.00M-4.29B-691.00M-843.00M45.23B44.72B41.52B37.42B31.25B28.08B22.57B21.94B21.27B18.52B17.23B8.28B7.65B6.68B5.49B3.94B3.23B
Operating Income67.73B96.28B40.82B36.06B37.05B20.89B11.92B13.50B29.73B26.43B25.98B21.66B19.31B12.63B10.61B11.19B3.36B11.25B1.45B-366.46M2.08B3.34B5.06B1.49B
Other Expenses / Income6.00B-35.80B-8.52B-7.74B-19.02B438.00M2.42B1.16B-2.59B1.73B627.00M19.00M-845.00M-186.00M-8.56B-15.19B80.44M-725.88M446.53M473.49M460.82M582.61M9.11M-426.12M
Before Tax Income71.87B60.48B32.30B28.32B18.03B22.44B14.34B14.65B27.14B28.16B26.61B21.68B18.47B12.44B2.05B-4.00B3.44B10.53B1.89B107.03M2.55B3.92B5.07B1.06B
Income Tax Expenses16.19B15.41B8.73B9.18B-1.47B3.65B4.54B2.61B7.13B5.98B5.09B4.90B4.20B1.40B985.00M1.17B-1.23B1.18B259.07M-94.28M69.41M396.92M153.68M320.24M
Net Income55.68B45.07B23.57B17.24B19.50B18.80B9.81B12.04B20.01B22.18B21.52B16.78B14.26B11.04B1.07B-5.17B4.68B9.35B1.63B211.27M2.48B3.52B4.92B739.28M
Interest Expenses1.71B1.43B958.00M970.00M983.00M1.16B788.00M634.00M826.00M1.09B1.27B1.02B1.07B362.00M372.00M1.67BN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding166.40M166.03M165.88M165.84M165.76M165.92M165.84M165.74M170.61M170.38M170.11M169.77M169.56M169.25M168.71M168.35M168.08M158.55M153.09M153.04M153.03M153.03M152.06M126.36M
Diluted Shares Outstanding166.71M166.38M166.34M166.32M166.08M166.20M166.20M167.00M171.05M170.87M170.68M170.43M170.19M169.85M169.62M168.35M168.69M159.26M153.40M153.12M153.10M153.03M152.30M126.36M
EBITDA82.57B108.78B52.64B48.86B49.53B23.61B26.84B26.56B38.22B37.35B34.99B28.24B24.75B16.95B6.58B1.49B9.65B13.55B3.46B1.43B3.68B4.93B6.01B1.95B
EBITDA Margin29.58%44.24%24.55%25.75%28.37%15.34%18.90%18.87%24.70%25.21%26.47%24.29%25.58%22.70%9.37%2.14%19.30%20.76%14.23%7.32%18.29%27.38%36.22%17.85%
EBIT73.58B61.91B33.26B27.38B19.02B23.61B15.13B15.29B27.97B29.25B27.88B22.70B19.53B12.80B2.42B-2.33B3.45B10.53B1.89B116.99M2.55B3.92B5.07B1.06B
EBIT Margin26.36%25.18%15.51%14.43%10.89%15.34%10.65%10.86%18.08%19.74%21.10%19.52%20.19%17.14%3.45%-3.35%6.90%16.14%7.78%0.60%12.67%21.75%30.53%9.69%
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙